Vantage Financial Partners (Wisconsin)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.54M Buy
11,120
+32
+0.3% +$7.29K 0.52% 31
2025
Q3
$2.57M Buy
11,088
+9
+0.1% +$1.83K 0.54% 30
2025
Q2
$2.06M Buy
11,079
+87
+0.8% +$16.2K 0.47% 40
2025
Q1
$2.3M Buy
10,992
+47
+0.4% +$9.14K 0.57% 28
2024
Q4
$1.94M Buy
10,945
+1,105
+11% +$203K 0.49% 31
2024
Q3
$1.94M Buy
+9,840
New +$1.84M 0.48% 25

Other funds holding ABBV

Vantage Financial Partners (Wisconsin)'s ABBV Position: Q4 2025 in Review

Vantage Financial Partners (Wisconsin) increased its AbbVie (ABBV) stake by 0.29% in Q4 2025, buying an estimated $7.29K and bringing the position to 11,120 shares worth $2.54M. The position accounts for 0.52% of the portfolio, ranked #31.

Vantage Financial Partners (Wisconsin) first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.57M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Vantage Financial Partners (Wisconsin) held 11,120 shares of AbbVie worth $2.54M as of Q4 2025.
  • Vantage Financial Partners (Wisconsin) bought 32 AbbVie shares in Q4 2025, an estimated $7.29K.
  • AbbVie made up 0.52% of Vantage Financial Partners (Wisconsin)'s portfolio in Q4 2025, its #31 holding.
  • Vantage Financial Partners (Wisconsin) first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
  • Vantage Financial Partners (Wisconsin)'s AbbVie position peaked at $2.57M in Q3 2025.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q4 2025, filed 3 Feb 2026.